SC
MRK icon

SRB Corp’s Merck MRK Stock Holding History

SRB Corp’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55.7M Sell
463,298
-10,067
-2% -$1.16M 3.42% 15
2025
Q4 		$49.8M Hold
473,365
– – 2.74% 15
2025
Q3 		$39.7M Sell
473,365
-23,181
-5% -$1.91M 2.28% 16
2025
Q2 		$39.3M Sell
496,546
-748,990
-60% -$59.5M 2.36% 17
2025
Q1 		$112M Sell
1,245,536
-51,897
-4% -$4.85M 7.29% 3
2024
Q4 		$129M Hold
1,297,433
– – 7.4% 4
2024
Q3 		$147M Sell
1,297,433
-30,154
-2% -$3.58M 8.26% 3
2024
Q2 		$164M Hold
1,327,587
– – 9.74% 2
2024
Q1 		$175M Hold
1,327,587
– – 9.7% 2
2023
Q4 		$145M Sell
1,327,587
-477,777
-26% -$49.6M 8.55% 2
2023
Q3 		$186M Sell
1,805,364
-3,865
-0.2% -$417K 11.26% 2
2023
Q2 		$209M Buy
1,809,229
+551
+0% +$62.6K 12.25% 2
2023
Q1 		$192M Sell
1,808,678
-39,729
-2% -$4.29M 12.11% 2
2022
Q4 		$205M Sell
1,848,407
-399
-0% -$40.8K 13.01% 2
2022
Q3 		$159M Sell
1,848,806
-11,182
-0.6% -$998K 11.11% 3
2022
Q2 		$170M Buy
1,859,988
+15,974
+0.9% +$1.42M 10.99% 3
2022
Q1 		$151M Hold
1,844,014
– – 8.41% 4
2021
Q4 		$141M Hold
1,844,014
– – 7.38% 5
2021
Q3 		$139M Hold
1,844,014
– – 8.33% 4
2021
Q2 		$143M Sell
1,844,014
-88,513
-5% -$6.58M 9.3% 3
2021
Q1 		$142M Sell
1,932,527
-10,140
-0.5% -$748K 9.71% 5
2020
Q4 		$152M Buy
1,942,667
+2,888
+0.1% +$221K 11.16% 4
2020
Q3 		$154M Buy
1,939,779
+757
+0% +$59.3K 12.85% 3
2020
Q2 		$143M Sell
1,939,022
-280
-0% -$21.1K 11.7% 3
2020
Q1 		$142M Buy
1,939,302
+368
+0% +$28.9K 13.25% 3
2019
Q4 		$168M Buy
1,938,934
+6,407
+0.3% +$526K 13.6% 3
2019
Q3 		$155M Hold
1,932,527
– – 13.64% 4
2019
Q2 		$155M Sell
1,932,527
-40,033
-2% -$3.07M 14.42% 3
2019
Q1 		$157M Hold
1,972,560
– – 14.73% 3
2018
Q4 		$144M Hold
1,972,560
– – 15.24% 3
2018
Q3 		$134M Hold
1,972,560
– – 13.3% 4
2018
Q2 		$114M Hold
1,972,560
– – 12.53% 4
2018
Q1 		$103M Hold
1,972,560
– – 12.97% 4
2017
Q4 		$106M Buy
1,972,560
+565,920
+40% +$31.4M 13.61% 4
2017
Q3 		$85.9M Hold
1,406,640
– – 11.35% 5
2017
Q2 		$86M Hold
1,406,640
– – 12.33% 4
2017
Q1 		$85.3M Hold
1,406,640
– – 12.09% 4
2016
Q4 		$79M Hold
1,406,640
– – 10.97% 6
2016
Q3 		$83.8M Hold
1,406,640
– – 12.24% 4
2016
Q2 		$77.3M Hold
1,406,640
– – 11.84% 6
2016
Q1 		$71M Sell
1,406,640
-2,813
-0.2% -$138K 11.18% 6
2015
Q4 		$71M Sell
1,409,453
-196,753
-12% -$9.92M 11.53% 6
2015
Q3 		$75.7M Buy
1,606,206
+11,571
+0.7% +$615K 10.39% 6
2015
Q2 		$86.7M Buy
1,594,635
+80,365
+5% +$4.51M 11.49% 4
2015
Q1 		$83.1M Hold
1,514,270
– – 11.63% 4
2014
Q4 		$82.1M Hold
1,514,270
– – 11.67% 5
2014
Q3 		$85.7M Hold
1,514,270
– – 12.43% 3
2014
Q2 		$83.6M Hold
1,514,270
– – 13.34% 2
2014
Q1 		$82M Hold
1,514,270
– – 13.44% 3
2013
Q4 		$72.3M Hold
1,514,270
– – 16.51% 2
2013
Q3 		$68.8M Hold
1,514,270
– – 15.83% 2
2013
Q2 		$67.1M Buy
+1,514,270
New +$67.6M 15.5% 3

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SRB Corp's MRK Position: Q1 2026 in Review

SRB Corp reduced its Merck (MRK) stake by 2.1% in Q1 2026, selling an estimated $1.16M and leaving 463,298 shares worth $55.7M. The position accounts for 3.42% of the portfolio, ranked #15.

SRB Corp first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $209M in Q2 2023. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • SRB Corp held 463,298 shares of Merck worth $55.7M as of Q1 2026.
  • SRB Corp sold 10,067 Merck shares in Q1 2026, an estimated $1.16M.
  • Merck made up 3.42% of SRB Corp's portfolio in Q1 2026, its #15 holding.
  • SRB Corp first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • SRB Corp's Merck position peaked at $209M in Q2 2023.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on SRB Corp's 13F filing for Q1 2026, filed 14 May 2026.